GENERAL: MLN: Marlin Global - Hat trick for Fisher International Funds
5 Mar 2010 10:40 am
MLN
05/03/2010
GENERAL
REL: 1040 HRS Marlin Global Limited
GENERAL: MLN: Marlin Global - Hat trick for Fisher International Funds
5 March, 2010
Hat trick for Fisher International Funds
International takeover activity continues to provide a significant boost to
New Zealand investors in Fisher Funds.
A third takeover offer for one of its international portfolio companies since
early January has lifted the value of units in the Fisher Funds International
Growth Fund, the Fisher Funds KiwiSaver Growth Scheme, and the shares of
listed company Marlin Global. All three funds are holders of shares in US
listed OSI Pharmaceuticals.
OSI Pharmaceutical has received an unsolicited bid from Astellas, a Japanese
pharmaceutical company ofUS$3.5billion, or US$52 per share, which is a more
than 40% premium to the current market price.
However, the stock closed yesterday above the takeover price, at US$56 per
share.
"There are other parties, such as Roche, who have an interest in acquiring
the company. Astellas has been pursuing OSI for more than a year now. The
price appreciation underscores the value in the franchise" says Fisher Funds
Senior Portfolio Manager Ken Applegate.
"We believe that merger and acquisition activity will be a significant
contributor to investment returns during the 2010 year. The global financial
crisis saw companies hunker down and tidy up balance sheets, to the extent
that many are now well placed to consider growth through acquisition."
In January the same three funds benefited from a 37% premium when the
management of Chinese shoe retailer Hongguo acquired the company while
Shiseido's acquisition of US company Bare Escentuals also brought a 40%
premium to the funds a few days earlier in the same month.
The Fisher Funds international portfolios specialise in investing in growth
businesses internationally and currently invest in 33 companies in Europe,
the US and Asia.